School of Medicine


Showing 101-120 of 274 Results

  • Cindy Kim

    Cindy Kim

    Clinical Research Coordinator Associate, Adult Neurology

    BioHello, Thank you for connecting with me through my profile. I developed a passion for health and wellness early in life which led me to pursue a B.S. in Health Education with an emphasis in Community Health. My direct patient care experience further solidified my dedication to improving patient outcomes and deepened my understanding of the healthcare system. Driven by my desire to expand my impact, I transitioned into my current role as Clinical Research Coordinator Associate at the Stanford Stroke Center, focusing on advancing the ability to predict stroke risks and improve patient health through the lens of research.

  • Lucas Kipp

    Lucas Kipp

    Clinical Associate Professor, Adult Neurology

    BioDr. Kipp specializes in the diagnosis and treatment of neuroimmunological disorders, particularly demyelinating conditions such as multiple sclerosis and neuromyelitis optica. He is interested in translational research connecting expert MS clinicians, world-renown immunology laboratories, and advanced neuroimaging techniques to identify biomarkers of disease and treatment response.

  • Hannah Louise Kirsch, MD

    Hannah Louise Kirsch, MD

    Clinical Associate Professor, Adult Neurology

    BioHannah Louise Kirsch, MD is a board-certified neurologist and a Clinical Assistant Professor in the Neurocritical Care Division of the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.

    Dr. Kirsch is also a hospitalist who pays special attention to delivering Stanford Health Care patients the best possible neurological care.

    She serves on the National Institute of Neurological Disorders and Stroke committee dedicated to coma and conditions related to consciousness. She has implemented numerous neurology-centered educational activities for health care professionals from diverse specialties, including training psychiatrists on the neuropsychiatric complications of COVID-19. She also has helped educate oncologists and hematologists regarding common neurological conditions among cancer patients.

    Dr. Kirsch has conducted research on a range of topics, including thrombotic complications in critically ill COVID-19 patients, advances in intracranial pressure monitoring, and predictors of outcomes in acute encephalitis. She has published her findings in Neurology, the Journal of Trauma, Emergency Medicine, and Procedures, among other journals.

    She has given presentations on topics including variations in coagulation among patients with cerebral hemorrhage and the association of cerebral pressure with cardiac arrest. She has shared her discoveries at meetings of the Neurocritical Care Society and Society of Hospital Medicine.

    The Neurocritical Care Society has honored her work. She also won the prestigious Leonard Tow Humanism in Medicine Award, which recognizes clinical excellence, outstanding compassion in the delivery of care, and respect for patients, families, and health care colleagues.

    Dr. Kirsch received her medical degree from New York University. She completed her residency in neurology at the University of California, San Francisco, and a fellowship in neurocritical care at Columbia University. She also completed the Columbia University narrative medicine certificate program and is board certified in neurology by the American Board of Psychiatry and Neurology.

  • Praneeta R. Konduri

    Praneeta R. Konduri

    Postdoctoral Scholar, Neurology and Neurological Sciences

    BioDr. Konduri is a Postdoctoral scholar at the Department of Neurology and Neurological Sciences. With a background in biomedical engineering, she conducted her PhD research as part of a European consortium that developed computational stroke models, while also analyzing post-treatment brain tissue damage from multicenter clinical trials to assess prognosis. After completing her PhD, she continued as a Postdoctoral Researcher within the European consortium GEMINI, that aimed to implement digital twins for personalized stroke treatment. At the Stanford Stroke Center, she now focusses on developing AI tools for stroke diagnosis, treatment evaluation, prognostication, and personalized treatment development.

  • Lironn Kraler, MD

    Lironn Kraler, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Kraler is a board-certified neurologist with subspecialty training in vascular neurology, and a Clinical Assistant Professor at Stanford University School of Medicine. Dr. Kraler is also the Associate Program Director for the Vascular Neurology Fellowship at Stanford.

    Before joining the faculty at Stanford, Dr. Kraler attended medical school at Keck School of Medicine at the University of Southern California where she was elected to the Alpha Omega Alpha National Honor Society. She completed her residency training at Stanford Hospital where she served as chief resident, followed by her Vascular Neurology fellowship training at Stanford. She then completed a post-doctoral research fellowship at Stanford University’s Clinical Excellence Research Center (CERC) focused on addressing the high cost of care in US Hospitals.

    Her research interests include improving access and quality of population health and developing high-value innovations in care delivery that decrease the cost of care while improving the quality to patients. In addition, she has a strong interest in medical education. Dr. Kraler has received recognition for outstanding medical student teaching from the Department of Neurology.

  • Prashanth Krishnamohan, MD

    Prashanth Krishnamohan, MD

    Clinical Associate Professor, Adult Neurology
    Clinical Associate Professor (By courtesy), Neurosurgery

    BioDr. Krishnamohan is a board-certified, fellowship-trained neurologist. He is a clinical assistant professor of neurology and neurological sciences and, by courtesy, of neurosurgery at Stanford University School of Medicine. In addition, he is Medical Director of the Neurosciences Service Line at Stanford Health Care – ValleyCare and is Medical Director of its Stroke program.

    Dr. Krishnamohan excels in the diagnosis and treatment of neurological conditions. His clinical interests include the management of stroke, epilepsy, concussion, and coma. With every patient, his goal is to provide personalized care designed to optimize neurological function for the best possible clinical outcome and quality of life.

    He has published extensively on topics including innovations in stroke care quality management and measurement, rapid bedside evaluation of seizures in the ICU, and EEG metrics in comatose cardiac arrest patients. Articles by Dr. Krishnamohan have appeared in Neuroanesthesia and Neurocritical Care, Quality Management in Healthcare, Current Infectious Disease Reports, and other journals. He has presented his research findings at the annual meetings of the Neurocritical Care Society and American Academy of Neurology.
    He has authored chapters on post-concussive syndrome, stroke, and other conditions for the guidebook Ferri’s Clinical Advisor. In addition, he is a reviewer for the Journal of Neuroscience Nursing, Neurohospitalist, and the Journal of Neurology, Neurosurgery, and Psychiatry.

    Dr. Krishnamohan has won recognition from Stanford Health Care, the Institute for Healthcare Improvement Open School, the University of Kentucky College of Medicine, and PSG Institute of Medical Sciences and Research – the latter two his alma maters.

    Dr. Krishnamohan is a member of the Neurocritical Care Society, American Academy of Neurology, and American Heart Association/American Stroke Association. He volunteers as a community health educator with numerous organizations.

  • Kathryn Kvam

    Kathryn Kvam

    Clinical Associate Professor, Adult Neurology
    Clinical Associate Professor (By courtesy), Neurosurgery

    Current Research and Scholarly InterestsDr. Kvam's research focuses on 1) how to measure quality of care for patients with neurologic disease, 2) the value and impact of neurohospitalist models of care on patient outcomes and trainee education and 3) outcomes in rare diseases like autoimmune encephalitis.

  • Shoeb Lallani

    Shoeb Lallani

    Resident in Adult Neurology
    Affiliate, Department Funds

    BioStanford Neurology Residency 2026 | Research in Schnitzer Lab | Interested in basal ganglia circuity and identification of molecular markers to serve as therapeutic targets for the treatment of movement disorders

  • Tenzin D. Lama, DNP, NP, CNL

    Tenzin D. Lama, DNP, NP, CNL

    Affiliate, Adult Neurology

    BioTenzin Lama received her DNP (Doctor of Nursing Practice) with Family Nurse Practitioner degree from University of San Francisco. She has also received her MSN- CNL (Clinic Nurse Leader) from the same university. Tenzin joined the Stanford Comprehensive Epilepsy Center in 2016 and has been working as a Nurse Practitioner in providing care and coordination of services for patients with Epilepsy.

  • Maarten Lansberg, MD, PhD

    Maarten Lansberg, MD, PhD

    Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsMy research involves the design and conduct of clinical trials to discover new treatments for patients who have suffered a stroke. These trials span treatment of acute stroke, stroke recovery, and stroke prevention. My research in acute stroke is primarily focused on the use of advanced neuroimaging methods (CT and MRI) to select patients who are most likely to benefit from therapies aimed at restoring blood flow to the brain in patients who have suffered a stroke.

  • Nicholas Wiessner Larsen, MD

    Nicholas Wiessner Larsen, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Larsen is a clinical assistant professor in the Department of Neurology, Division of Autonomic Disorders. He is a board-certified neurologist and a fellowship-trained specialist in neurophysiology and autonomics. He completed medical school at the University of Utah and neurology residency and fellowship at Stanford.

    In his clinical practice, Dr. Larsen focuses on disorders of the autonomic nervous system (ANS). His research interest is in the long-term autonomic complications of COVID-19. He is the principal investigator of a study looking at post-COVID postural tachycardia syndrome.

    Dr. Larsen’s research interests also include Global Health Neurology. Dr. Larsen helped establish the first stroke unit in Rwanda and is part of the American Academy of Neurology’s Refugees & Asylum Seekers Working Group.

    He has co-authored articles for publication in Clinical Autonomic Research, Autonomic Neuroscience, Nature Climate Change, and elsewhere. He is a recipient of the American Academy of Neurology Medical Student Prize for Excellence as well as a member of the Alpha Omega Alpha Honor Medical Society.

  • Amira Latif Hernandez

    Amira Latif Hernandez

    Instructor, Adult Neurology

    BioAmira obtained her Ph.D. in Neuroscience from the KU Leuven, Belgium, in summer 2017. During her doctoral studies, she used clinically valid tests of murine cognition, neuronal plasticity measures in hippocampal and cortical slices, brain lesion methods, pharmacological applications and resting state functional magnetic resonance imaging to characterize the pathophysiology of novel mouse models of Alzheimer’s disease (AD). One of her most gratifying contributions was the development of a new electrophysiology tool to assess synaptopathies, and the establishment of long-term synaptic plasticity from prefrontal cortex of APP knock-in mice. In Autumn 2017, she moved to Dr. Longo’s lab at the Stanford School of Medicine, where she investigates signaling pathways involved in synaptic degeneration. During 3 years of postdoctoral work, she established a multi-electrode array system with eight independent recording chambers that allows high-throughput analyses of multiple long-lasting forms of synaptic plasticity. She also gained experience in RNA-sequencing, molecular biochemistry, signaling mechanisms, target validation and drug development strategies for AD. In October 2020, Amira has been appointed as an Instructor in Neurodegenerative Disease Research, in the Longo lab, to help develop improved and more powerful approaches that will better reveal key synaptic mechanisms and candidate modules associated with neuroplasticity and affected in AD mouse models, by identifying activity-dependent gene expression signatures.

  • Scheherazade Le, MD

    Scheherazade Le, MD

    Clinical Professor, Adult Neurology

    Current Research and Scholarly InterestsNeurophysiology, Epilepsy/EEG, Intraoperative Neurophysiologic Monitoring,Tuberous Sclerosis, Autoimmune Epilepsy/Encephalitis, Autoimmune Encephalitis, Immune-Mediated Epilepsy